TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma.

MLA

Xu, Xiaoqin, et al. “TMPRSS4 Is a Novel Biomarker and Correlated with Immune Infiltration in Thyroid Carcinoma.” BMC Endocrine Disorders, vol. 22, no. 1, Nov. 2022, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12902-022-01203-3.

APA

Xu, X., Sun, T., & Jing, J. (2022). TMPRSS4 is a novel biomarker and correlated with immune infiltration in thyroid carcinoma. BMC Endocrine Disorders, 22(1), 1–12. https://doi.org/10.1186/s12902-022-01203-3

Chicago

Xu, Xiaoqin, Ting Sun, and Jiexian Jing. 2022. “TMPRSS4 Is a Novel Biomarker and Correlated with Immune Infiltration in Thyroid Carcinoma.” BMC Endocrine Disorders 22 (1): 1–12. doi:10.1186/s12902-022-01203-3.